ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

By Gareth Macdonald

- Last updated on GMT

The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011. asked representatives from Quintiles Transnational, PRA International and Theorem Clinical Research to share their thoughts on such deals and whether they are good for the sector as a whole.

We also spoke with John Lewis, Vice President of Public Affairs at the Association of Clinical Research Organizations (ACRO) who suggested that more research is needed to assess the efficacy of strategic partnerships.

Related news

Show more

Related products


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers